David A. Lowe
Directeur Général chez NeuroAssets Sàrl
Profil
Dr. David A.
Lowe is President & Chief Executive Officer at NeuroAssets Sàrl.
He is on the Board of Directors at Amarantus Bioscience Holdings, Inc.
Dr. Lowe was previously employed as Chief Scientific Officer by Memory Pharmaceuticals Corp., Chief Scientific Officer by Fidelity Biosciences Corp., VP & Therapeutic Area Head-Central Nervous System by Roche Palo Alto LLC, VP & Global Head-Central Nervous System Research by Bayer AG, and President & Chief Executive Officer by FORUM Pharmaceuticals, Inc.
He received his undergraduate degree from the University of Bristol and a doctorate degree from the University of Leeds.
Postes actifs de David A. Lowe
| Sociétés | Poste | Début |
|---|---|---|
| NeuroAssets Sàrl | Directeur Général | - |
Anciens postes connus de David A. Lowe
| Sociétés | Poste | Fin |
|---|---|---|
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Directeur/Membre du Conseil | 22/10/2015 |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Directeur Technique/Scientifique/R&D | 01/01/2004 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | 01/01/2002 |
| BAYER AG | Corporate Officer/Principal | 01/01/2000 |
FORUM Pharmaceuticals, Inc.
 FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | President | - |
Formation de David A. Lowe
| University of Bristol | Undergraduate Degree |
| University of Leeds | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BAYER AG | Health Technology |
| AMARANTUS BIOSCIENCE HOLDINGS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Memory Pharmaceuticals Corp.
 Memory Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Memory Pharmaceuticals Corp. develops pharmaceutical products for the treatment of debilitating central nervous system (CNS) disorders such as Alzheimer's disease and schizophrenia. The company was founded by Axel Unterbeck in 1998 and is headquartered in Montvale, NJ. | Health Technology |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Finance |
FORUM Pharmaceuticals, Inc.
FORUM Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology FORUM Pharmaceuticals, Inc. was engaged in the development of therapeutics for disorders of the central nervous system (CNS). It focused on discovering and developing treatments for important neurodegenerative diseases that explore novel mechanisms of action to potentially alter the progression of brain disease and provided improvement in cognitive and overall function. The company was founded by Thorsten Melcher in 2001 and was headquartered in Waltham, MA. | Health Technology |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
| NeuroAssets Sàrl |